CNS Infection Safety Signal of RTS,S/AS01 and Possible Association With Rabies Vaccine

The Lancet - United Kingdom
doi 10.1016/s0140-6736(16)30081-2
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants

New England Journal of Medicine
Medicine
2008English

The RTS,S/AS01 Malaria Vaccine in Children 5 to 17 Months of Age at First Vaccination

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

Combining Antimalarial Drugs and Vaccine for Malaria Elimination Campaigns: A Randomised Safety and Immunogenicity Trial of RTS,S/AS01 Administered With Dihydroartemisinin, Piperaquine and Primaquine in Healthy Thai Adult Volunteers

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

Efficacy and Safety of RTS,S/AS01 Malaria Vaccine With or Without a Booster Dose in Infants and Children in Africa: Final Results of a Phase 3, Individually Randomised, Controlled Trial

The Lancet
Medicine
2015English

Statistical Methodology for the Evaluation of Vaccine Efficacy in a Phase III Multi-Centre Trial of the RTS,S/AS01 Malaria Vaccine in African Children

Malaria Journal
ParasitologyInfectious Diseases
2011English

Pooled Analysis of Safety Data From Pediatric Phase II RTS,S/AS Malaria Candidate Vaccine Trials

Human Vaccines
2011English

Assessment of Severe Malaria in a Multicenter, Phase III, RTS, S/As01 Malaria Candidate Vaccine Trial: Case Definition, Standardization of Data Collection and Patient Care

Malaria Journal
ParasitologyInfectious Diseases
2011English

Breadth of Human Monoclonal Antibodies Isolated From RTS,S/AS01 Vaccinees Binding to Plasmodium Falciparum Circumsporozoite Protein Antigens

Biophysical Journal
Biophysics
2019English

Policy Analysis for Deciding on a Malaria Vaccine RTS,S in Tanzania

Malaria Journal
ParasitologyInfectious Diseases
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy